Download PDF
Dtsch Med Wochenschr 2011; 136(48): 2483-2485
DOI: 10.1055/s-0031-1297272
Nephrologie | Commentary
Nephrologie
© Georg Thieme Verlag KG Stuttgart · New York

Störungen des Wasser- und Elektrolythaushalts

Disorders of fluid and electrolyte balanceR. Kettritz1 , 2 , F. C. Luft2
  • 1Nephrologie und Internistische Intensivmedizin, Universitätsmedizin Charite Virchow-Klinikum Berlin
  • 2Experimental and Clinical Research Center (ECRC), Campus Buch, Berlin
Further Information

Publication History

Publication Date:
22 November 2011 (online)

Also available at
    Permissions and Reprints

Corrected by:

Störungen des Wasser- und ElektrolythaushaltsDtsch Med Wochenschr 2012; 137(05): 229-229
DOI: 10.1055/s-0031-1297280

Schlüsselwörter

Hyponatriämie - Tolvaptan - Desmopressin - Natriumkanäle - Durstregulation

Keywords

hyponatremia - tolvaptan - desmopressin - natrium channels - regulation of thirst

Literatur

  • 1 Berl T, Quittnat-Pelletier F, Verbalis J G. et al . Oral tolvaptan is safe and effective in chronic hyponatremia.  J Am Soc Nephrol. 2010;  21 705-712
    Google Scholar
  • 2 Berl T, Rastegar A. A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion.  Am J Kidney Dis. 2010;  55 742-748
    Google Scholar
  • 3 Einhorn L M, Zhan M, Hsu V D. et al . The frequency of hyperkalemia and its significance in chronic kidney disease.  Arch Intern Med. 2009;  169 1156-1162
    Google Scholar
  • 4 Hiyama T Y, Matsuda S, Fujikawa A. et al . Autoimmunity to the sodium-level sensor in the brain causes essential hypernatremia.  Neuron. 2010;  66 508-522
    Google Scholar
  • 5 Konstam M A, Gheorghiade M, Burnett J C Jr. et al . Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.  JAMA. 2007;  297 1319-1331
    Google Scholar
  • 6 Korgaonkar S, Tilea A, Gillespie B W. et al . Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study.  Clin J Am Soc Nephrol. 2010;  5 762-769
    Google Scholar
  • 7 Perianayagam A, Sterns R H, Silver S M. et al . DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.  Clin J Am Soc Nephrol. 2008;  3 331-336
    Google Scholar
  • 8 Schrier R W, Gross P, Gheorghiade M. et al . Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.  N Engl J Med. 2006;  355 2099-2112
    Google Scholar
  • 9 Suzuki H, Sugimura Y, Iwama S. et al . Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia.  J Am Soc Nephrol. 2010;  21 2090-2098
    Google Scholar
  • 10 Tian W, Fu Y, Garcia-Elias A. et al . A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia.  Proc Natl Acad Sci U S A. 2009;  106 14034-14039
    Google Scholar
  • 11 Wang C J, Lin Y N, Huang S W. et al . Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study.  J Urol. 2011;  185 219-223
    Google Scholar

Prof. Dr. med. Ralph Kettritz

Universitätsmedizin Berlin
Charité Campus Buch
Experimental and Clinical Research Center

Lindenberger Weg 80

13125 Berlin

Phone: 030/450540002

Fax: 030/450540900

Email: kettritz@charite.de

      >